Suppr超能文献

选择性雌激素受体调节剂(SERMs)在小胶质细胞中的抗炎作用。

Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.

作者信息

Suuronen T, Nuutinen T, Huuskonen J, Ojala J, Thornell A, Salminen A

机构信息

Department of Neuroscience and Neurology, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland.

出版信息

Inflamm Res. 2005 May;54(5):194-203. doi: 10.1007/s00011-005-1343-z.

Abstract

OBJECTIVE

Our aim was to study how different SERMs modulate the inflammatory responses induced by lipopolysaccharide (LPS) or unmethylated CpG-oligonucleotides in mouse and rat microglial cells.

MATERIALS AND METHODS

Inflammatory responses of mouse N9 microglial cells and rat primary hippocampal microglia to lipopolysaccharide (LPS) exposure were recorded by the secretion of nitric oxide (NO) and cytokine IL-6 in two models where SERM was added either 24 h before LPS addition or simultaneously or even after the LPS exposure. The responses of 17beta-estradiol, tamoxifen, raloxifene and ICI 182.780 were compared. Responses were recorded by ELISA, Northern and EMSA assays.

RESULTS

SERMs but not 17beta-estradiol induced a significant, concentration-dependent anti-inflammatory response both in rat primary microglial cells and in mouse N9 microglial cells. The response was observed both in NO and IL-6 secretion as well as in total IL-6 mRNA expression. We have recently observed that histone deacetylase (HDAC) inhibitors can potentiate the LPS-induced inflammatory response. Raloxifene and tamoxifen inhibited the potentiation of LPS response induced by trichostatin A, an HDAC inhibitor, in N9 microglia. A SERM-induced anti-inflammatory response was observed in acute models where SERM was added simultaneously or even up to 6 h later than LPS exposure. In contrast, the pretreatment of N9 microglia with tamoxifen or raloxifene for 30 h before LPS exposure did not provide any protection against the LPS response. We also observed that the raloxifene-induced protection in N9 microglia was connected to a decline of LPS-induced DNA binding activity of AP-1 but not that of NF-kappaB transcription factors.

CONCLUSIONS

Our results show that tamoxifen, raloxifene and ICI 182.780 induce an anti-inflammatory response in acute models of mouse and rat microglial cells. It seems that this response is not estrogen receptor-mediated but, probably, is attributable to some SERM-induced modulation of LPS-activated pro-inflammatory signalling cascades.

摘要

目的

我们的目的是研究不同的选择性雌激素受体调节剂(SERM)如何调节脂多糖(LPS)或未甲基化的CpG寡核苷酸在小鼠和大鼠小胶质细胞中诱导的炎症反应。

材料与方法

在两个模型中,通过一氧化氮(NO)和细胞因子IL-6的分泌来记录小鼠N9小胶质细胞和大鼠原代海马小胶质细胞对脂多糖(LPS)刺激的炎症反应。在添加LPS前24小时、同时或甚至在LPS刺激后添加SERM。比较了17β-雌二醇、他莫昔芬、雷洛昔芬和ICI 182.780的反应。通过酶联免疫吸附测定(ELISA)、Northern印迹和电泳迁移率变动分析(EMSA)测定来记录反应。

结果

SERM而非17β-雌二醇在大鼠原代小胶质细胞和小鼠N9小胶质细胞中均诱导了显著的、浓度依赖性的抗炎反应。在NO和IL-6分泌以及总IL-6 mRNA表达方面均观察到了该反应。我们最近观察到组蛋白脱乙酰酶(HDAC)抑制剂可增强LPS诱导的炎症反应。雷洛昔芬和他莫昔芬抑制了HDAC抑制剂曲古抑菌素A在N9小胶质细胞中诱导的LPS反应增强。在急性模型中,当SERM与LPS同时添加甚至在LPS刺激后6小时添加时,观察到了SERM诱导的抗炎反应。相反,在LPS刺激前用他莫昔芬或雷洛昔芬预处理N9小胶质细胞30小时并不能对LPS反应提供任何保护。我们还观察到雷洛昔芬在N9小胶质细胞中诱导的保护作用与LPS诱导的AP-1 DNA结合活性下降有关,但与NF-κB转录因子无关。

结论

我们的结果表明,他莫昔芬、雷洛昔芬和ICI 182.780在小鼠和大鼠小胶质细胞急性模型中诱导抗炎反应。这种反应似乎不是由雌激素受体介导的,而是可能归因于某些SERM诱导的对LPS激活的促炎信号级联反应的调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验